Relief Therapeutics Holding SA (RLFTF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 11:00AM EDT. Market open.
| Previous close | 1.3900 |
| Open | 1.3900 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 1.3900 - 1.3900 |
| 52-week range | 1.2000 - 8.4000 |
| Volume | |
| Avg. volume | 2,486 |
| Market cap | 17.261M |
| Beta (5Y monthly) | -14.37 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -8.0400 |
| Earnings date | 29 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireEton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call pointTransaction is expected to be accretive to 2024 earningsEstimated peak sales of more than $10 million annuallyU.S. phenylketonuria ("PKU") medical formula market estimated to be $100 million annually DEER PARK, Ill., March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company foc
© 2024 Yahoo. All rights reserved.